FTXH / First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF - Institutionelt ejerskab - Købere

First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF, omfatter Raymond James Financial Inc .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-12 13F Ameritas Investment Partners, Inc. 15.711 2,55 403 -4,51
2025-08-12 13F LPL Financial LLC 109.007 3,91 2.794 -3,12
2025-08-14 13F UBS Group AG 3.996 37,51 102 29,11
2025-08-15 13F Morgan Stanley 5.916 0,02 152 -6,79
2025-08-14 13F Raymond James Financial Inc 2.225 57
2025-08-05 13F Bank Of Montreal /can/ 8.221 68,19 211 56,72
2025-08-12 13F Proequities, Inc. 0 0
2025-07-31 13F Cambridge Investment Research Advisors, Inc. 16.986 2,53 0
2025-08-14 13F Goldman Sachs Group Inc 32.186 65,29 825 54,02
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista